Anti-human CD161 Antibody
英诺赛图(InnoCyto)的 Anti-human CD161 Antibody(克隆 HP-3G10) 为鼠源 IgG1 单克隆抗体,靶向 CD161(别名 NKR-P1A 等),Purified 标记,适用于流式细胞术。提供 25 μg、100 μg 规格,目录价 ¥746 起,仅供科研使用(RUO)。
01产品图片

02产品简介
英诺赛图(InnoCyto)的 Anti-human CD161 Antibody(克隆 HP-3G10) 为鼠源 IgG1 单克隆抗体,靶向 CD161(别名 NKR-P1A 等),Purified 标记,适用于流式细胞术。提供 25 μg、100 μg 规格,目录价 ¥746 起,仅供科研使用(RUO)。
03产品介绍
规格与货号
114701 | 25 μg | ¥746
114702 | 100 μg | ¥1,492
Product Details
Regulatory Status|RUO
Protein Concentration|0.5 mg/mL
Recommended Usage|For flow cytometric staining, it is recommended to use less than 0.2 μg of this reagent per 0.5-1.0 million cells in a 100 µL volume. Optimal reagent performance should be determined by titration for each specific application
See All Formats|Clone HP-3G10
Background Information
CD161, also known as KLRB1 (killer cell lectin-like receptor subfamily B member 1), is a C-type lectin receptor expressed on natural killer (NK) cells, subsets of T cells—including mucosal-associated invariant T (MAIT) cells—and some Th17 cells. It plays a role in modulating immune responses, particularly in balancing activation and inhibition during immune surveillance and inflammation.
Structurally, CD161 is a type II transmembrane protein with a short N-terminal cytoplasmic domain, a single transmembrane region, and an extracellular C-type lectin-like domain responsible for ligand binding. Unlike classical lectins, it does not bind carbohydrates in a calcium-dependent manner but instead recognizes protein ligands.
The primary ligand for CD161 is LLT1 (lectin-like transcript 1, CLEC2D), which is expressed on activated immune cells such as B cells, dendritic cells, and some tumor cells. Interaction between CD161 and LLT1 generally delivers inhibitory signals that can dampen NK and T-cell cytotoxicity and cytokine production, although context-dependent activating effects have also been reported.
In disease, CD161 is implicated in autoimmune disorders, infectious diseases, and cancer. Its expression marks IL-17–producing T cells involved in inflammatory pathology. In tumors, CD161–LLT1 interactions may contribute to immune evasion. Therapeutically, targeting this pathway is under investigation to enhance anti-tumor immunity or modulate inflammatory responses.
Data Sheets
Human peripheral blood lymphocytes were stained with PB anti-Human CD4 clone OKT4 and Purified anti-Human CD161 clone HP-3G10 (left) or an isotype control (right) , followed by PE anti-Mouse IgG.
04完整参数表
参数由厂商资料整理,采购前请以最终报价单与技术协议为准。
05荣誉与资质
该品牌暂未上传荣誉证书与资质文件。以下是平台可核验的公开信息,未上传项如实标注,不做推断。
- 营业执照未上传
- 品牌授权未上传
- 产品检测报告未上传
- 会员身份
- 收费会员
- 经营身份
- 原厂
- 成立年份
- 2020 年
- 所在地
- 上海
- 收录条目
- 1865 个
- 平台核验
- 平台代管
06品牌与供应商
InnoCyto(上海英诺赛图生物科技有限公司)致力于通过开发高质量细胞分析试剂,加速科学发现进程。公司为研究人员提供细胞层面探索所需的工具,推动免疫学、肿瘤学等多领域的研究创新。 核心团队拥有丰富的行业经验,曾参与全球头部生命科学公司的标杆项目搭建,深刻理解工业界与学术研究的前沿需求。试剂从设计之初即以精确性、一致性、高性能为核心标准,让科学家能把精力集中在最核心的研究工作上。 公司将深厚的科学积累与对品质的严格承诺相结合,力争成为全球研究人员信赖的合作伙伴。产品线覆盖经验证的一抗与二抗、同型对照、生物类似药抗体、重组蛋白、细胞因子、免疫检测试剂盒及配套试剂,并提供重组蛋白/抗体表达与标记偶联服务。
品牌资料由厂商公开信息与授权渠道核对整理;条目参数与价格以最终报价单为准。
07同类条目
同一子类内的条目才具备可比性。跨子类比较参数通常没有意义。
08同品牌其他条目
上海英诺赛图 在本目录共 1865 个条目,除本条外还有:
科研在线(TeleVM). Anti-human CD161 Antibody(114701)[EB/OL]. 产品目录, 2026-11-12. https://www.suprotek.cn/products/item/anti-human-cd161-antibody.html.
TeleVM. (2026, November 12). Anti-human CD161 Antibody(114701). 产品目录. https://www.suprotek.cn/products/item/anti-human-cd161-antibody.html
@misc{biocsp_item_anti_human_cd161_antibody,
title = {Anti-human CD161 Antibody(114701)},
author = {{科研在线}},
year = {2026},
howpublished = {产品目录},
note = {更新于 2026-11-12,产品目录},
url = {https://www.suprotek.cn/products/item/anti-human-cd161-antibody.html}
}
GB/T 7714 用于中文论文与报告;APA 7 用于英文期刊;BibTeX 可直接导入 Zotero、EndNote 或 LaTeX。
许可:CC BY-NC 4.0 · 转载注明来源